MEFV and familial Mediterranean fever: To exclude false positives as much as possible before subsequent confirmatory binding assays, and to identify pyrin-binding proteins which interact with pyrin via its PRY/SPRY (B30.2) domain where mutations are often observed in patients with FMF, we also performed the screening using the C-terminal region of pyrin molecule (C-pyrin; aa 598–781) as bait.